XML 87 R71.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies - Loss per share, Warrants and Options expirations (Details) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded 800,924 117,692 739,222 42,853  
Weighted average exercise price, outstanding warrants $ 24.00        
Weighted average exercise price, outstanding options 87.15 $ 435.32 $ 90.58 $ 435.32 $ 593.92
Pontifax | First 588,599 shares of common stock issuable upon conversion | Convertible Debt          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Conversion price     $ 27.20    
Weighted Average          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Conversion price $ 138.24 $ 453.92      
Common stock purchase warrants          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded 408,640   408,640 42  
Stock options          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded 56,568 11,946 56,609 11,946  
Convertible debt          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded 335,716 105,746 273,973 30,865